CTI BioPharma Corp.

NASDAQ: CTIC · Real-Time Price · USD
9.10
0.01 (0.11%)
At close: Jun 23, 2023, 9:58 PM

CTI BioPharma Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2022 FY 2021
Period Ending Dec 31, 2022 Dec 31, 2021
PE Ratio
-7.57 -2.24
PEG Ratio
0.26 -0.04
PS Ratio
12.78 n/a
PB Ratio
-39.22 59.33
P/FCF Ratio
-6.49 -2.63
P/OCF Ratio
-8.49 -2.63
OCF/S Ratio
-1.51 n/a
Debt / Equity Ratio
-2.84 13.42
Quick Ratio
1.22 1.03
Current Ratio
1.23 1.03
Asset Turnover
0.43 n/a
Interest Coverage
-6.07 -39.47
Return on Equity
5.18 -26.45
Return on Assets
-0.72 -1.38
Return on Invested Capital
-0.84 -1.79
Dividend Yield
n/a n/a
Payout Ratio
n/a n/a
Gross Profit Margin
0.93 n/a
Net Profit Margin
-1.69 n/a
Pretax Profit Margin
-1.72 n/a
Operating Profit Margin
-1.48 n/a
FCF Margin
n/a n/a
EBITDA Margin
-1.48 n/a